Japan Generic Market To Grow By 40% By 2016 – Fuji Keizai
This article was originally published in PharmAsia News
Executive Summary
The Japanese generic drugs market is expected to be worth ¥777.9 billion ($7.4 billion) by 2016, with anti-hypertensive agents, dyslipidemia drugs, and anti-cancer drugs leading the way, according to research released by Fuji Keizai.